Le Lézard
Classified in: Health
Subjects: MAV, SCZ, CFG

Media Advisory - Minister Schulte to announce investment in seniors in Waterloo


GATINEAU, QC, Feb. 13, 2020 /CNW/ - The Honourable Deb Schulte, Minister of Seniors, along with Marwan Tabbara, Member of Parliament for Kitchener South?Hespeler, will announce how the Government of Canada, in partnership with the Schlegel-UW Research Institute for Aging, is helping to address isolation in older adults living with dementia in the Waterloo Region.

A photo opportunity and media availability will follow the announcement.

Please note that all details are subject to change. All times are local.

 

DATE:

Friday, February 14, 2020



TIME:

12:45 p.m.



PLACE:

Schlegel-UW Research Institute for Aging                                 


250 Laurelwood Drive


Discovery Hall


Waterloo, Ontario          

 

Follow us on Twitter

SOURCE Employment and Social Development Canada


These press releases may also interest you

at 10:19
Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits...

at 10:17
Fx Chocolate®, a Designs for Health brand that provides functional amounts of high-quality supplements in handcrafted chocolate, today announced the launch of its Yes Whey!!!tm chocolate supplement bar. Yes Whey!!!tm harnesses 15 grams of...

at 10:16
Varian, a Siemens Healthineers Company, announces its collaboration with BaraSeen Medical Company to introduce the first Halcyon system in Saudi Arabia - with its hallmark sustainability features - at BaraSeen's initial specialized standalone Batik-X...

at 10:15
From the childhood dream of becoming a veterinarian and saving the lives of pets, to today's realities of practicing veterinary medicine, the deep commitment veterinarians feel for their calling remains unchanged. However, certain factors make that...

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:02
Boston Institute of Biotechnology, LLC (BIB) in collaboration with BIBo-Biopharma, proudly announces the successful completion of a groundbreaking 30,000L fermentation run, marking a significant milestone in biotechnology history....



News published on and distributed by: